Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management.
cell-free DNA
liquid biopsy
thyroid cancer
thyroid diseases
thyroid nodules
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
31 Oct 2022
31 Oct 2022
Historique:
received:
29
09
2022
revised:
26
10
2022
accepted:
28
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Thyroid cancer is the most frequent endocrine malignancy with an increasing incidence trend during the past forty years and a concomitant rise in cancer-related mortality. The circulating cell-free DNA (cfDNA) analysis is a patient's friendly and repeatable procedure allowing to obtain surrogate information about the genetics and epigenetics of the tumor. The aim of the present review was to address the suitability of cfDNA testing in different forms of thyroid cancer, and the potential clinical applications, as referred to the clinical weaknesses. Despite being limited by the absence of standardization and by reproducibility and validity issues, cfDNA assessment has great potential for the improvement of thyroid cancer management. cfDNA may support the pre-surgical definition of thyroid nodules by complementing invasive thyroid fine needle aspiration cytology. In addition, it may empower risk stratification and could be used as a biomarker for monitoring the post-surgical disease status, both during active surveillance and in the case of anti-tumor treatment.
Identifiants
pubmed: 36358788
pii: cancers14215370
doi: 10.3390/cancers14215370
pmc: PMC9654679
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Minerva Endocrinol (Torino). 2022 Mar;47(1):99-102
pubmed: 33213117
Eur J Cancer. 2017 Apr;75:213-221
pubmed: 28237867
Endocr Relat Cancer. 2016 Nov;23(11):R499-R515
pubmed: 27578827
Endocr Pract. 2016 May;22(5):622-39
pubmed: 27167915
Nat Rev Endocrinol. 2017 Nov;13(11):644-660
pubmed: 28707679
Clin Endocrinol (Oxf). 1998 Mar;48(3):265-73
pubmed: 9578814
J Clin Endocrinol Metab. 2009 Dec;94(12):5001-9
pubmed: 19850689
Endocr Pract. 2021 Jul;27(7):673-681
pubmed: 33601025
J Clin Endocrinol Metab. 2003 Mar;88(3):1107-11
pubmed: 12629092
Eur J Cancer. 2018 Nov;103:165-175
pubmed: 30253333
Thyroid. 2021 Aug;31(8):1235-1243
pubmed: 33599171
Am J Cancer Res. 2020 Jul 01;10(7):1923-1936
pubmed: 32774993
Eur Thyroid J. 2021 Feb;9(6):304-312
pubmed: 33718254
Eur J Endocrinol. 2008 Feb;158(2):239-46
pubmed: 18230832
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):784-91
pubmed: 19240234
Thyroid. 2010 Dec;20(12):1341-9
pubmed: 21034228
J Clin Endocrinol Metab. 2008 Mar;93(3):682-7
pubmed: 18073307
Gland Surg. 2020 Jan;9(Suppl 1):S28-S42
pubmed: 32055496
Cancer. 2006 Mar 15;106(6):1286-95
pubmed: 16470605
Thyroid. 2016 Apr;26(4):518-24
pubmed: 26872102
Clin Endocrinol (Oxf). 2004 Jul;61(1):61-74
pubmed: 15212646
Nat Rev Cancer. 2013 Mar;13(3):184-99
pubmed: 23429735
J Clin Endocrinol Metab. 2012 Feb;97(2):517-24
pubmed: 22170714
J Clin Endocrinol Metab. 2005 Nov;90(11):6077-84
pubmed: 16091497
Clin Chem. 2015 Sep;61(9):1191-6
pubmed: 26206882
Clin Cancer Res. 2019 Dec 15;25(24):7370-7380
pubmed: 31558473
Crit Rev Oncol Hematol. 2015 Jan;93(1):60-73
pubmed: 25240824
Mol Aspects Med. 2020 Apr;72:100828
pubmed: 31711714
Endocr Relat Cancer. 2018 Mar;25(3):L7-L11
pubmed: 29192093
Mol Cancer Ther. 2017 Jul;16(7):1412-1420
pubmed: 28446639
J Clin Oncol. 2012 Jan 10;30(2):134-41
pubmed: 22025146
J Clin Endocrinol Metab. 2006 Jan;91(1):98-104
pubmed: 16263813
J Clin Endocrinol Metab. 2002 Oct;87(10):4595-601
pubmed: 12364440
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2262-e2270
pubmed: 33475693
Biomed Pharmacother. 2013 Oct;67(8):723-30
pubmed: 23931930
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22
pubmed: 24557566
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Endocr Relat Cancer. 2009 Mar;16(1):17-44
pubmed: 18987168
World J Surg. 2004 Jul;28(7):721-6
pubmed: 15185002
Int J Mol Sci. 2017 Jun 24;18(7):
pubmed: 28672797
Methods Mol Biol. 2013;1049:75-82
pubmed: 23913210
Head Neck. 2018 Aug;40(8):1752-1758
pubmed: 29566452
Eur J Endocrinol. 2011 Sep;165(3):441-6
pubmed: 21750043
Head Neck. 2013 Nov;35(11):1630-3
pubmed: 23161556
Yonsei Med J. 2015 May;56(3):634-40
pubmed: 25837167
J Clin Oncol. 2013 Oct 10;31(29):3639-46
pubmed: 24002501
BMC Res Notes. 2017 Oct 30;10(1):532
pubmed: 29084579
Nat Rev Clin Oncol. 2011 Aug 23;8(10):587-96
pubmed: 21862978
J Clin Endocrinol Metab. 2012 Aug;97(8):2748-53
pubmed: 22679061
Endocrine. 2018 Oct;62(1):71-75
pubmed: 29749566
Nat Rev Clin Oncol. 2013 Aug;10(8):437-50
pubmed: 23799370
Clin Cancer Res. 2019 Aug 1;25(15):4691-4700
pubmed: 30988079
Expert Opin Med Diagn. 2011 Jul;5(4):277-90
pubmed: 23484549
J Clin Med. 2020 Aug 02;9(8):
pubmed: 32748840
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):E5503-12
pubmed: 26392541
Endocr Relat Cancer. 2004 Mar;11(1):131-9
pubmed: 15027890
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Cancers (Basel). 2020 Feb 07;12(2):
pubmed: 32046148
Cancer Res. 2001 Feb 15;61(4):1659-65
pubmed: 11245480
Cancer Sci. 2020 Jun;111(6):2163-2173
pubmed: 32187423
J Clin Endocrinol Metab. 2003 Apr;88(4):1433-41
pubmed: 12679418
Thyroid. 2017 Jan;27(1):81-87
pubmed: 27785980
Comput Struct Biotechnol J. 2018 Oct 09;16:370-378
pubmed: 30364656
Thyroid. 2021 Dec;31(12):1822-1828
pubmed: 34541884
JAMA. 2017 Apr 4;317(13):1338-1348
pubmed: 28362912
Thyroid. 2016 Mar;26(3):404-13
pubmed: 26541309
Cancers (Basel). 2021 Oct 22;13(21):
pubmed: 34771467
Sci Transl Med. 2017 Aug 16;9(403):
pubmed: 28814544
J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
pubmed: 16684830
Int J Biol Markers. 2020 Sep;35(3):41-49
pubmed: 33073682
J Clin Endocrinol Metab. 2002 May;87(5):1941-6
pubmed: 11994321
Cancers (Basel). 2021 Jul 27;13(15):
pubmed: 34359686
Anticancer Res. 2022 May;42(5):2289-2299
pubmed: 35489725
J Clin Endocrinol Metab. 2013 May;98(5):E934-42
pubmed: 23533235
Endocrinol Metab Clin North Am. 2014 Jun;43(2):401-21
pubmed: 24891169
Int J Endocrinol. 2021 Aug 23;2021:8909224
pubmed: 34475951
Thyroid. 2017 Nov;27(11):1341-1346
pubmed: 29091573
Thyroid. 2015 May;25(5):538-50
pubmed: 25747526
Clin Cancer Res. 2005 Feb 1;11(3):1219-25
pubmed: 15709192
Endocrinol Metab Clin North Am. 1995 Dec;24(4):761-801
pubmed: 8608779
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4609-4616
pubmed: 30137493
Ann Surg Oncol. 2011 Sep;18(9):2461-8
pubmed: 21416156
Thyroid. 2013 Nov;23(11):1401-7
pubmed: 23517313
Crit Rev Oncol Hematol. 2021 Jun;162:103353
pubmed: 34000414
Clin Endocrinol (Oxf). 1999 Oct;51(4):509-15
pubmed: 10583320
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3591-3599
pubmed: 28911154
Ann Oncol. 2018 Mar 1;29(3):610-615
pubmed: 29253083
Thyroid. 2021 Mar;31(3):337-386
pubmed: 33728999
Endocrine. 2022 May;76(2):491-494
pubmed: 35152349
World J Surg. 2007 May;31(5):934-45
pubmed: 17431717
Thyroid. 2002 Aug;12(8):707-11
pubmed: 12225639
Int J Clin Oncol. 2014;19(3):445-51
pubmed: 23832286
N Engl J Med. 1998 Jan 29;338(5):297-306
pubmed: 9445411
J Clin Endocrinol Metab. 2013 Aug;98(8):3359-65
pubmed: 23788690
J Clin Endocrinol Metab. 2012 Jul;97(7):2333-40
pubmed: 22508706
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3420-e3427
pubmed: 35470851
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18761-8
pubmed: 24191000
Front Oncol. 2021 Feb 04;10:602153
pubmed: 33634024
JAMA Surg. 2018 Jan 1;153(1):52-59
pubmed: 28973144
J Mol Diagn. 2018 Sep;20(5):686-702
pubmed: 29936259
Nat Med. 2014 Apr;20(4):430-5
pubmed: 24658074
Cancer Metastasis Rev. 2016 Sep;35(3):347-76
pubmed: 27392603
Lancet. 2013 Mar 23;381(9871):1046-57
pubmed: 23668555
J Clin Endocrinol Metab. 2006 Jan;91(1):313-9
pubmed: 16263822